Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) EPS (Weighted Average and Diluted) (2020 - 2025)

Historic EPS (Weighted Average and Diluted) for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to -$0.01.

  • Stemtech's EPS (Weighted Average and Diluted) changed 0.0% to -$0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.02, marking a year-over-year increase of 8750.0%. This contributed to the annual value of -$0.03 for FY2024, which is 5115.95% up from last year.
  • According to the latest figures from Q3 2025, Stemtech's EPS (Weighted Average and Diluted) is -$0.01, which was down 0.0% from -$0.0 recorded in Q2 2025.
  • In the past 5 years, Stemtech's EPS (Weighted Average and Diluted) ranged from a high of $0.38 in Q3 2022 and a low of -$0.56 during Q2 2022
  • For the 5-year period, Stemtech's EPS (Weighted Average and Diluted) averaged around -$0.03, with its median value being -$0.01 (2022).
  • Within the past 5 years, the most significant YoY rise in Stemtech's EPS (Weighted Average and Diluted) was 23571.43% (2022), while the steepest drop was 270000.0% (2022).
  • Stemtech's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.02 in 2021, then skyrocketed by 50.98% to -$0.01 in 2022, then tumbled by 89.68% to -$0.02 in 2023, then skyrocketed by 85.04% to -$0.0 in 2024, then crashed by 199.3% to -$0.01 in 2025.
  • Its last three reported values are -$0.01 in Q3 2025, -$0.0 for Q2 2025, and -$0.01 during Q1 2025.